Table 3.

Summary of estimated cases, non-discounted and discounted total costs and life-years of a single age-cohort (n = 25,000) of 12 year old girls

		Screening only	Bivalent*	Quadrivalent*
Cases
	Cervical cancer	229	32	53
	Deaths from cervical cancer	144	20	33
	CIN Persistent 2n3 detected	2,073	294	480
	CIN 2n3 detected	382	135	168
	CIN 1 detected	2,109	1,127	1,293
	Genital warts	4,126	4,126	447
NON-DISCOUNTED
Total costs		21,150,496	25,020,340	22,822,396
	Vaccine costs	-	10,000,000	10,000,000
	Screening costs	11,006,014	9,949,324	10,078,234
	CIN1 treatment costs	2,330,522	1,245,203	1,292,796
	CIN 2 & 3 treatment costs	564,776	199,475	247,908
	CIN Persistent 2 & 3 treatment costs	3,067,301	435,141	710,367
	Genital warts treatment costs	3,094,714	3,094,714	335,580
	Cervical cancer treatment costs	1,087,169	96,483	157,511
Life-years (LY)		1,692,651	1,695,651	1,695,338
QALYs		1,717,089	1,720,571	1,720,299
DISCOUNTED
Total costs		6,880,106	15,034,926	14,210,399
Life-years (LY)		711,164	711,800	711,734
QALYs		735,991	736,775	736,784

*In addition to screening